Norris Medicines Limited SHARE PRICE [LIVE]
BSE: INE744C01029 NSE: - SECTOR: -
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Mar 21 | Dec 20 |
|---|
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Norris Medicines Limited
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
News
- JEEVAN SCIENTIFIC TECHNOLOGY LTD
- KHAITAN ELECTRICALS LTD.
- ASL INDUSTRIES LIMITED
- ADD-SHOP E-RETAIL LIMITED
- CHHATTISGARH INDUSTRIES L
- AMARNATH SECURITIES LTD
- ADITYA BIRLA CAPITAL LTD
- CHARMS INDUSTRIES LTD.
- SINGER INDIA LIMITED
- CIL NOVA PETROCHEMICALS LTD.
- RUNEECHA TEXTILES LTD.
- PANYAM CEMENTS & MINERAL INDUSTRIES LTD.
- COROMANDEL AGRO PRODUCTS & OILS LIMITED
- TATA STEEL LTD.
- SYNTHIKO FOILS LTD.
- SKYPAK SERVICE SPECIALIST LTD.
- ASHIRWAD CAPITAL LTD.
- ELANTAS BECK INDIA LTD.
- REMI EDELSTAHL TUBULARS LIMITED
- ELEGANT MARBLES & GRANI INDUSTRIES LTD.
Frequently Asked Questions
Can I buy Norris Medicines Limited () shares?
How do I buy Norris Medicines Limited () from Angel One?
- Direct investment: You can buy Norris Medicines Limited () shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Norris Medicines Limited () shares.
About
Today's live share price for Norris Medicines Limited is NSE: N/A, BSE: N/A with a current market capitalization of .
Incorporated on 7 Sep.'90 as a private limited company and promoted by B N Thakore, N J Patel and N L Upadhyaya, Norris Medicines is purely a pharmaceutical formulations-based company. It became a public limited company in Mar.'92. Commercial production of the formulation unit commenced in Nov.'91. The company came out with a public issue aggregating Rs 5 cr in Dec.'93 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project cost of Rs 14.21 cr was financed through loans and equity. The project was delayed by about nine months and was completed in 1995. The company undertakes job work/loan license work of reputed pharmaceuticals majors and expects to continue with the present arrangement besides expecting big boost in exports in the coming years with the PHC groups focus and marketing strengths worldwide.
Read more
